Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anterix (ATEX) EBT (2016 - 2025)

Historic EBT for Anterix (ATEX) over the last 13 years, with Q4 2025 value amounting to -$8.7 million.

  • Anterix's EBT fell 21574.37% to -$8.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $85.2 million, marking a year-over-year increase of 39479.98%. This contributed to the annual value of -$9.5 million for FY2025, which is 2614.77% down from last year.
  • Per Anterix's latest filing, its EBT stood at -$8.7 million for Q4 2025, which was down 21574.37% from $61.1 million recorded in Q3 2025.
  • Anterix's 5-year EBT high stood at $61.1 million for Q3 2025, and its period low was -$14.3 million during Q2 2024.
  • For the 5-year period, Anterix's EBT averaged around -$219200.0, with its median value being -$8.2 million (2022).
  • In the last 5 years, Anterix's EBT tumbled by 56122.15% in 2024 and then surged by 58702.94% in 2025.
  • Anterix's EBT (Quarter) stood at -$12.3 million in 2021, then skyrocketed by 36.52% to -$7.8 million in 2022, then surged by 121.33% to $1.7 million in 2023, then surged by 348.74% to $7.5 million in 2024, then tumbled by 215.74% to -$8.7 million in 2025.
  • Its EBT was -$8.7 million in Q4 2025, compared to $61.1 million in Q3 2025 and $22.9 million in Q2 2025.